Angel Roman

Array ( [id] => 20722311 [patent_doc_number] => 20260139014 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-21 [patent_title] => CHIMERIC NEUROTOXINS [patent_app_type] => utility [patent_app_number] => 19/423511 [patent_app_country] => US [patent_app_date] => 2025-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9726 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19423511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20694025 [patent_doc_number] => 20260125431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-05-07 [patent_title] => CHIMERIC NEUROTOXINS [patent_app_type] => utility [patent_app_number] => 19/341888 [patent_app_country] => US [patent_app_date] => 2025-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9639 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19341888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20584096 [patent_doc_number] => 20260069686 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-03-12 [patent_title] => CD8 BINDING AGENTS [patent_app_type] => utility [patent_app_number] => 19/238731 [patent_app_country] => US [patent_app_date] => 2025-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37957 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19238731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20656565 [patent_doc_number] => 20260108599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-04-23 [patent_title] => THERAPEUTIC COMPOUND AND METHOD OF PREPARING A THERAPEUTIC VACCINE FOR THE TREATMENT OF ALLERGIC AND AUTOIMMUNE DISEAES USING IMMUNIZATION WITH ENGINEERED BACTERIAL DNA OR CpG MOTIFS DERIVIDE FROM COMMENSAL BACTERIA SUCH AS Bifidobacterium longun subsp. infantis. [patent_app_type] => utility [patent_app_number] => 18/831298 [patent_app_country] => US [patent_app_date] => 2024-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18831298 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19746072 [patent_doc_number] => 20250034637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => LONG LIFETIME ALPHA-HEMOLYSIN NANOPORES [patent_app_type] => utility [patent_app_number] => 18/798279 [patent_app_country] => US [patent_app_date] => 2024-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14886 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18798279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19512078 [patent_doc_number] => 20240343764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-17 [patent_title] => COMPOSITIONS FOR AND METHODS OF TREATING AND/OR PREVENTING MALARIA [patent_app_type] => utility [patent_app_number] => 18/661538 [patent_app_country] => US [patent_app_date] => 2024-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52735 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19526707 [patent_doc_number] => 20240350609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF [patent_app_type] => utility [patent_app_number] => 18/637620 [patent_app_country] => US [patent_app_date] => 2024-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27811 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 379 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18637620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19541814 [patent_doc_number] => 20240358850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-31 [patent_title] => COMPOSITIONS AND METHODS FOR AN ANTIBODY DRUG CONJUGATE DIRECTED TO A NON-CELL SURFACE THERAPEUTIC TARGET [patent_app_type] => utility [patent_app_number] => 18/633864 [patent_app_country] => US [patent_app_date] => 2024-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21511 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18633864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20287152 [patent_doc_number] => 20250312395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => PHARMACEUTICAL COMPOSITION FOR ALLEVIATIONN, TREATMENT, AND PREVENTION OF SARCOPENIA CONTAINING MICROORGANISM TRANSFORMED WITH CELL SURFACE DISPLAY VECTOR OPERABLY LINKED WITH GENE ENCODING MYOSTATIN AND ACTIVIN A PROTEINS AS ACTIVE INGREDIENT [patent_app_type] => utility [patent_app_number] => 18/627462 [patent_app_country] => US [patent_app_date] => 2024-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19496464 [patent_doc_number] => 20240335482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-10 [patent_title] => BACTERIAL TREATMENT FOR ATOPIC DERMATITIS [patent_app_type] => utility [patent_app_number] => 18/627124 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2166 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20287151 [patent_doc_number] => 20250312394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-10-09 [patent_title] => Lacticaseibacillus Rhamnosus DY801 and Application Thereof [patent_app_type] => utility [patent_app_number] => 18/627441 [patent_app_country] => US [patent_app_date] => 2024-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1555 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18627441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359310 [patent_doc_number] => 20240261344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => Method of alleviating symptoms of depression and anxiety by use of a novel Bacillus coagulans strain [patent_app_type] => utility [patent_app_number] => 18/609012 [patent_app_country] => US [patent_app_date] => 2024-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10706 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18609012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20444004 [patent_doc_number] => 20260000718 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-01 [patent_title] => BIFIDOBACTERIUM BREVE FOR IMPROVING AGING-RELATED COGNITIVE DISORDER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/833541 [patent_app_country] => US [patent_app_date] => 2023-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1896 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18833541 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19170964 [patent_doc_number] => 20240156938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HUMAN CHLAMYDIAL INFECTIONS AND DISEASES USING ATTENUATED ANIMAL CHLAMYDIA [patent_app_type] => utility [patent_app_number] => 18/506636 [patent_app_country] => US [patent_app_date] => 2023-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23666 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18506636 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19156094 [patent_doc_number] => 20240148801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => MITIGATION OF PATHOGENS IN PORCINE SPECIES [patent_app_type] => utility [patent_app_number] => 18/504114 [patent_app_country] => US [patent_app_date] => 2023-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13302 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18504114 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19297398 [patent_doc_number] => 20240225963 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2024-07-11 [patent_title] => PROBIOTICS REVITALIZING SYSTEM FOR SKINCARE [patent_app_type] => utility [patent_app_number] => 18/493751 [patent_app_country] => US [patent_app_date] => 2023-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12362 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19297398 [patent_doc_number] => 20240225963 [patent_country] => US [patent_kind] => A9 [patent_issue_date] => 2024-07-11 [patent_title] => PROBIOTICS REVITALIZING SYSTEM FOR SKINCARE [patent_app_type] => utility [patent_app_number] => 18/493751 [patent_app_country] => US [patent_app_date] => 2023-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12362 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18493751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18953676 [patent_doc_number] => 20240042003 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-08 [patent_title] => CROSS-PROTECTIVE ANTIGENS FOR VACCINATION [patent_app_type] => utility [patent_app_number] => 18/483888 [patent_app_country] => US [patent_app_date] => 2023-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18483888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18893801 [patent_doc_number] => 20240009286 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES [patent_app_type] => utility [patent_app_number] => 18/234902 [patent_app_country] => US [patent_app_date] => 2023-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16995 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18234902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18987655 [patent_doc_number] => 20240059624 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => CELLULOSIMICROBIUM CELLULANS STRAIN AND USE THEREOF IN STRAW FIELD COMPOSTING [patent_app_type] => utility [patent_app_number] => 18/350084 [patent_app_country] => US [patent_app_date] => 2023-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18350084 [rel_patent_id] =>[rel_patent_doc_number] =>)